Enhanced Investments - Financial Portal

Dealings in Securities by Directors and Prescribed Officers of Sasol and Directors of Major Subsidiaries of Sasol

Published: 2023-03-08 17:00:34 ET

Sasol Limited
(Incorporated in the Republic of South Africa)
(Registration number 1979/003231/06)
Sasol Ordinary Share codes:       JSE: SOL               NYSE: SSL
Sasol Ordinary ISIN codes:        ZAE000006896           US8038663006
Sasol BEE Ordinary Share code: JSE: SOLBE1
Sasol BEE Ordinary ISIN code: ZAE000151817
(Sasol or the Company)

DEALINGS IN SECURITIES BY DIRECTORS AND PRESCRIBED OFFICERS OF
SASOL LIMITED AND DIRECTORS OF MAJOR SUBSIDIARIES OF SASOL LIMITED

In compliance with paragraphs 3.63 to 3.66 of the JSE Limited Listings Requirements
(Listings Requirements), the following information is disclosed relating to dealings in
securities of Sasol by the executive directors and prescribed officers of Sasol, and
directors of its major subsidiaries.

The persons below have transacted in securities awarded and accepted in 2020 in terms
of the rules of the Sasol Long-Term Incentive (LTI) Plan.

The 2020 award partly vested at the achievement of corporate performance targets
(CPTs) at 54.31%. The balance of the LTI award made in 2020 will vest in 2025 subject to
the rules of the Plan.

Participants have the option to retain all shares; sell sufficient shares to cover the tax
liability and retain the balance thereof; or, to sell the vested shares. The dealings are as
set out below.

 Transaction date:                6 March 2023
 Class of securities:             Sasol ordinary shares
 Issue price per share:           R0,00
 Nature of transaction:           Retention of vested shares off-market
 Nature and extent of interest:   Direct beneficial

 Name            Company and designation                   Number         Price per   Total value of
                                                             of            share           the
                                                           shares          (ZAR)       transaction
                                                                                          (ZAR)
 H C Brand       Sasol Limited: Prescribed officer            3 500          271,82       951 370,00
 F R Grobler     Sasol Limited: Director                     15 580          271,82     4 234 955,60
 V D Kahla       Sasol Limited: Director                      6 827          271,82     1 855 715,14
                 Sasol Oil (Pty) Ltd: Director
                 Sasol South Africa Limited: Director
 C K Mokoena     Sasol Limited: Prescribed officer             5 074         271,82    1 379 214,68
                 Sasol South Africa Limited: Director
                 Sasol Oil (Pty) Ltd: Director

 Transaction date:                6 March 2023
 Class of securities:             Sasol ordinary shares
 Issue price per share:           R0,00
 Nature of transaction:           Sale of vested shares on-market
 Nature and extent of interest:   Direct beneficial
 Name                           Company and designation                                Number          Selling         Total value
                                                                                         of           Price per           of the
                                                                                       shares           share          transaction
                                                                                                       (ZAR)*             (ZAR)
 H C Brand                      Sasol Limited: Prescribed officer                         11 746      270,4039         3 176 164,21
 F R Grobler                    Sasol Limited: Director                                   14 381      270,4039         3 888 678,48
 V D Kahla                      Sasol Limited: Director                                    6 301      270,4039         1 703 814,97
                                Sasol Oil (Pty) Ltd: Director
                                Sasol South Africa Limited: Director
 C K Mokoena                    Sasol Limited: Prescribed officer                          4 682       270,4039        1 266 031,06
                                Sasol South Africa Limited: Director
                                Sasol Oil (Pty) Ltd: Director
* Average selling price per share is based on transactions effected by the Company on 6 March 2023. Proceeds are allocated to the
  shares sold by directors / prescribed officers, as with all employees, based on the outcome of the bulk sale.


The highest and lowest prices, as well as the VWAP price for the day of trading are as follows:

 Date                              Highest price         Lowest price            Volume Weighted Average Price
                                   (ZAR)                 (ZAR)                   (ZAR)
 6 March 2023                      271,80                269,33                  270,4039

 Transaction date:                             6 March 2023
 Class of securities:                          Sasol American Depositary Receipts (ADR) each representing one
                                               Sasol ordinary share
 Issue price per share:                        USD0,00
 Nature of transaction:                        Retention of vested shares off-market
 Nature and extent of interest:                Direct beneficial

 Name                    Company and designation                                  Number           Price per         Total value of
                                                                                    of              share                 the
                                                                                  shares            (USD)             transaction
                                                                                                                         (USD)
 B V Griffith            Sasol Limited: Prescribed officer                             4 733             15,23            72 083,59
                         Sasol Chemicals (USA) LLC: Director

 Transaction date:                             6 March 2023
 Class of securities:                          Sasol American Depositary Receipts (ADR) each representing one
                                               Sasol ordinary share
 Issue price per share:                        USD0,00
 Nature of transaction:                        Sale of vested shares on-market
 Nature and extent of interest:                Direct beneficial

 Name                       Company and designation                                Number           Selling   Total value of
                                                                                     of            Price per        the
                                                                                   shares            share     transaction
                                                                                                    (USD)*        (USD)
 B V Griffith               Sasol Limited: Prescribed officer                          2 438          14,7139      35 872,49
                            Sasol Chemicals (USA) LLC: Director
* Average selling price per share is based on transactions effected by the Company on 6 March 2023. Proceeds are allocated to the
  shares sold by directors / prescribed officers, as with all employees, based on the outcome of the bulk sale.
The highest and lowest prices, as well as the VWAP price for the day of trading are as follows:

 Date                                       Highest       Lowest         Volume Weighted
                                            price         price          Average Price
                                            (USD)         (USD)          (USD)
 6 March 2023                               14,90         14,60          14,7139

In terms of paragraph 3.66 of the Listings Requirements, the necessary clearance to deal
has been obtained for the transactions set out above.

8 March 2023
Sandton

Sponsor: Merrill Lynch South Africa (Pty) Limited t/a BofA Securities

Enhanced Investments, Inc.
329 South Oyster Bay Road #2085
Plainview, NY 11803
team@eninvs.com

Important disclosures

Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities.
Past performance is no guarantee of future results. Any historical returns, expected returns [or probability projections] are hypothetical in nature and may not reflect actual future performance.
All the strategies assume investments in equity invstrumenta only and are more relevant for "agressive investment profile". Eastern European flagship strategy assumes using up to 20% leverage of total portfolio. GlobalCommodities and US Growth strategy currently assume no leverage.
Results for the Enhanced Investments strategies as compared to the performance of Illustrative Benchmarks is for informational purposes only. Our investment program does not mirror that of the Illustrative Benchmarks and the volatility may be materially different from the volatility of Illustrative Benchmarks. Reference or comparison to an Illustrative Benchmark does not imply that strategies of Enhanced Investments will be constructed in the same way as the Illustrative Benchmark or achieve returns, volatility, or other results similar to those of the Illustrative Benchmark. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance.
Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.